Skip to main content

ophthalmology

Sreelakshmi-Vasudevan-feat
Hero Type
Image
Postdoc of the Month: Sreelakshmi Vasudevan
Sreelakshmi Vasudevan is focused on helping people keep their sight. Originally from Kerala, India, Vasudevan is a postdoctoral scholar in Case Western Reserve University School of Medicine’s Department of Ophthalmology and Visual Sciences working alongside Paul Park. In the lab, Vasudevan research...
GettyImages-1081574962-scaled-e1630683016808
Hero Type
Image
Visual Sciences Research Center's 2022 annual symposium
For the first time since 2019, the Case Western Reserve University Visual Sciences Research Center (VSRC) will hold its annual symposium in person. The event will be held Friday, May 20, from 9 a.m. to 4:30 p.m., in the Wolstein Research Building Auditorium. The day's keynote speaker will be Ula V...
eye1
Hero Type
Image
Case Western Reserve and University Hospitals researchers receive multi-year grants to identify genetic biomarkers of susceptibility and resistance to corneal ulcers
More than 125 million people worldwide wear contact lenses, and while many are exposed to relatively common bacteria through their contact lenses, not all contract an eye infection. Researchers at the Case Western Reserve School of Medicine and University Hospitals (UH) Cleveland Medical Center wi...
eye1
Hero Type
Image
New study offers added hope for patients awaiting corneal transplants
Donor tissue can be stored for 11 days before transplantation—four days longer than current convention New national research led by Jonathan Lass of Case Western Reserve University School of Medicine has found that corneal donor tissue can be safely stored for 11 days before transplantation surgery ...
opthomology
Hero Type
Image
Alevca Ocular gains CWRU Technology Transfer licenses to develop and commercialize novel ophthalmological drugs
Alevca Ocular LLC has secured licenses from Case Western Reserve University’s Technology Transfer Office (TTO) to exclusively use university-funded research to develop and commercialize novel ophthalmological drugs. Alevca Ocular, an early-stage company based in San Clemente, California, has licens...